InsidersTradesSigma
基于 5 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by 홍성한, 董事长兼首席执行官. Officer active across 2 companies, notably 비씨월드제약. Cumulatively, 22 filings have been published. History available since 26 March 2026. The latest transaction was filed on 28 April 2026 (Other). Regulator: DART (FSS). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 条申报中的 22 条
Hong Sung-han is the chairman and CEO of BC World Pharmaceutical, an innovative pharmaceutical company. He leads all operations and defines the company's strategic vision. His role is pivotal for the growth and development of the organization in the market.